Victims Who Have Used Zantac® And Have Been Diagnosed With Liver Cancer Are Urged To Request a Free, Private Case Evaluation For Justice and Substantial Compensation

Victims Who Have Used Zantac® And Have Been Diagnosed With Liver Cancer Are Urged To Request a Free, Private Case Evaluation For Justice and Substantial Compensation

Some of the liver cancer symptoms that consumers of Zantac® (aka ranitidine®) consumers should be wary of may include:

  • Weight loss (without trying)
  • Loss of appetite
  • Feeling very full after a small meal
  • Nausea or vomiting
  • An enlarged liver, felt as fullness under the ribs on the right side
  • An enlarged spleen, felt as fullness under the ribs on the left side

FREE CLAIM REVIEW

Did you take any of the following Medications? (Check all that Apply)(Required)
To qualify, Please Check All that Apply(Required)
Name(Required)

By clicking the "Free Case Review" button, I consent to receive recurring auto dialed and/or pre-recorded telemarketing calls and/or text messages from Shield Legal LP or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal LP Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.

100% confidential Case Evaluations

Answer a few basic questions to get started

Receive a confidential case evaluation

Have an individual claim filed for compensation

What consumers must be aware about the link between liver cancer and Zantac® (aka ranitidine®)

Due to detected levels of a probable human carcinogen in ranitidine® medications, taking Zantac® increases the risk of developing liver cancer.

Zantac® (aka ranitidine®) lawyers agree that people must satisfy a few conditions to potentially qualify for a lawsuit–including proven Zantac® (aka ranitidine®) use plus a liver cancer diagnosis and ultimately a connection between the liver cancer diagnosis and Zantac® (aka ranitidine®) .

Only a Shield Legal Network lawyer can properly evaluate a claim, as well as help gather medical records and evidence to build a case.

    • Brand name Zantac® (aka ranitidine®) use. Potential claimants have to prove they took the brand name Zantac® made with ranitidine®–or a proof of prescription for those who see a physician–for at least one year before being diagnosed with liver cancer.
    • Demonstrate a liver cancer diagnosis. The primary injury claimed in Zantac® and ranitidine® lawsuits must be liver cancer–and potential claimants having a diagnosis of liver cancer.
  • Connection Between Cancer Diagnosis and Zantac. Taking higher medication doses can serve to help prove the connection–as well as the length of time someone has used the drug.

Consumers with a history of taking Zantac® who have been diagnosed with liver cancer can file a legal claim against ranitidine® manufacturers for justice and compensation.

Billions in profits made on unsafe Medication

How does Zantac® (aka ranitidine®) cause liver cancer?

Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.

Initially approved only for short-term use by the Federal Drug Administration (FDA) due to its potential to cause cancer in long-term use, Zantac® was then marketed for long-term use without appropriate warnings.

Since Zantac® (aka ranitidine®) contains dangerously high levels of a potentially dangerous chemical called N-nitrosodimethylamine (NDMA), it has potentially been linked to several types of lifelong cancers–namely liver cancer.

Shield Legal Network believes that liver cancer victims should get the justice and compensation they deserve by addressing the makers of Zantac® (aka ranitidine®) in a court of law. 

Zantac® and Liver Cancer in the News

2021

Researchers found those who used ranitidine regularly were 1.9 times more likely to have liver cancer.

2020

On February 6, 2020, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Zantac liver cancer lawsuits into the Southern District of Florida.

2019

Though many companies recalled their ranitidine products in the latter part of 2019, the FDA did not require an overall recall of the medication until April 1, 2020.

100% FREE CASE EVALUATION. SEE IF YOU QUALIFY TODAY!

Please seek the advice of a medical professional before making health care decisions. This advertisement is not associated with a Zantac®, Sanofi®, Zantac's® generic manufacturers, or any government agency.